The Vaginal Microbiota and Its Association with Human Papillomavirus, Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium Infections: a Systematic Review and Meta-analysis

Overview

Journal Clin Microbiol Infect

Publisher Elsevier

Specialty Infectious Diseases

Date 2018 May 6

PMID 29729331

Citations 81

Authors

J Tamarelle

A C M Thiebaut

B De Barbeyrac

C Bebear

J Ravel

E Delarocque-Astagneau

Affiliations

Soon will be listed here.

Abstract

Background: The vaginal microbiota may modulate susceptibility to human papillomavirus (HPV), Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections. Persistent infection with a carcinogenic HPV is a prerequisite for cervical cancer, and C. trachomatis, N. gonorrheae and M. genitalium genital infections are all associated with pelvic inflammatory disease and subsequent infertility issues.

Objectives: To evaluate the association between these infections and the vaginal microbiota.

Data Sources: The search was conducted on Medline and the Web of Science for articles published between 2000 and 2016.

Study Eligibility Criteria: Inclusion criteria included a measure of association for vaginal microbiota and one of the considered STIs, female population, cohort, cross-sectional and interventional designs, and the use of PCR methods for pathogen detection.

Methods: The vaginal microbiota was dichotomized into high-Lactobacillus vaginal microbiota (HL-VMB) and low-Lactobacillus vaginal microbiota (LL-VMB), using either Nugent score, Amsel's criteria, presence of clue cells or gene sequencing. A random effects model assuming heterogeneity among the studies was used for each STI considered.

Results: The search yielded 1054 articles, of which 39 met the inclusion criteria. Measures of association with LL-VMB ranged from 0.6 (95% CI 0.3-1.2) to 2.8 (95% CI 0.3-28.0), 0.7 (95% CI 0.4-1.2) to 5.2 (95% CI 1.9-14.8), 0.8 (95% CI 0.5-1.4) to 3.8 (95% CI 0.4-36.2) and 0.4 (95% CI 0.1-1.5) to 6.1 (95% CI 2.0-18.5) for HPV, C. trachomatis, N. gonorrhoeae and M. genitalium infections, respectively.

Conclusions: Although no clear trend for N. gonorrhoeae and M. genitalium infections could be detected, our results support a protective role of HL-VMB for HPV and C. trachomatis. Overall, these findings advocate for the use of high-resolution characterization methods for the vaginal microbiota and the need for longitudinal studies to lay the foundation for its integration in prevention and treatment strategies.

Citing Articles

Getting Everyone on Board to Break the Cycle of Bacterial Vaginosis (BV) Recurrence: A Qualitative Study of Partner Treatment for BV.

King A, Phillips T, Plummer E, Wild N, Fairley C, Chow E Patient. 2025; .

PMID: 40085319 DOI: 10.1007/s40271-025-00731-z.

Exploring the Clinical Signatures of Cervical Dysplasia Patients and Their Association With Vaginal Microbiota.

Cheng L, Yan C, Yang Y, Hong F, Du J Cancer Med. 2024; 13(23):e70440.

PMID: 39641435 PMC: 11622153. DOI: 10.1002/cam4.70440.

The correlation between vaginal pathogens and high-risk human papilloma virus infection: a meta-analysis of case-control studies.

Yang J, Long X, Li S, Zhou M, Hu L Front Oncol. 2024; 14:1423118.

PMID: 39640283 PMC: 11618108. DOI: 10.3389/fonc.2024.1423118.

Chinese advances in understanding and managing genitourinary tract infections caused by Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma urealyticum.

Qiu Y, Mao S, Li X, Chen Y, Chen W, Wen Y Arch Microbiol. 2024; 207(1):5.

PMID: 39607610 DOI: 10.1007/s00203-024-04204-z.

Menstruation myths.

Sommer M, Chrisler J, Yong P, Carneiro M, Koistinen I, Brown N Nat Hum Behav. 2024; 8(11):2086-2089.

PMID: 39567737 DOI: 10.1038/s41562-024-02057-6.

References

Blas M, Canchihuaman F, Alva I, Hawes S . Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State. Sex Transm Infect. 2007; 83(4):314-8. PMC: 2598687. DOI: 10.1136/sti.2006.022665. View

Aroutcheva A, Gariti D, Simon M, Shott S, Faro J, Simoes J . Defense factors of vaginal lactobacilli. Am J Obstet Gynecol. 2001; 185(2):375-9. DOI: 10.1067/mob.2001.115867. View

Veldhuijzen N, Snijders P, Reiss P, Meijer C, van de Wijgert J . Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010; 10(12):862-74. DOI: 10.1016/S1473-3099(10)70190-0. View

Rizzo A, Fiorentino M, Buommino E, Donnarumma G, Losacco A, Bevilacqua N . Lactobacillus crispatus mediates anti-inflammatory cytokine interleukin-10 induction in response to Chlamydia trachomatis infection in vitro. Int J Med Microbiol. 2015; 305(8):815-27. DOI: 10.1016/j.ijmm.2015.07.005. View

Tommasino M . The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2013; 26:13-21. DOI: 10.1016/j.semcancer.2013.11.002. View

de Martel C, Plummer M, Vignat J, Franceschi S . Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4):664-670. PMC: 5520228. DOI: 10.1002/ijc.30716. View

Zozaya-Hinchliffe M, Lillis R, Martin D, Ferris M . Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol. 2010; 48(5):1812-9. PMC: 2863870. DOI: 10.1128/JCM.00851-09. View

Voravuthikunchai S, Bilasoi S, Supamala O . Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli. Anaerobe. 2006; 12(5-6):221-6. DOI: 10.1016/j.anaerobe.2006.06.003. View

Hutchinson K, Kip K, Ness R . Condom use and its association with bacterial vaginosis and bacterial vaginosis-associated vaginal microflora. Epidemiology. 2007; 18(6):702-8. DOI: 10.1097/EDE.0b013e3181567eaa. View

10.

Newman L, Rowley J, Vander Hoorn S, Wijesooriya N, Unemo M, Low N . Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One. 2015; 10(12):e0143304. PMC: 4672879. DOI: 10.1371/journal.pone.0143304. View

11.

Lamont R, Sobel J, Akins R, Hassan S, Chaiworapongsa T, Kusanovic J . The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011; 118(5):533-49. PMC: 3055920. DOI: 10.1111/j.1471-0528.2010.02840.x. View

12.

Detels R, Green A, Klausner J, Katzenstein D, Gaydos C, Handsfield H . The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis. 2012; 38(6):503-9. PMC: 3408314. View

13.

Olmsted S, Meyn L, Rohan L, Hillier S . Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis. 2003; 30(3):257-61. DOI: 10.1097/00007435-200303000-00016. View

14.

Kaewsrichan J, Peeyananjarassri K, Kongprasertkit J . Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol Med Microbiol. 2006; 48(1):75-83. DOI: 10.1111/j.1574-695X.2006.00124.x. View

15.

Morris M, Rogers P, Kinghorn G . Is bacterial vaginosis a sexually transmitted infection?. Sex Transm Infect. 2001; 77(1):63-8. PMC: 1758329. DOI: 10.1136/sti.77.1.63. View

16.

Gajer P, Brotman R, Bai G, Sakamoto J, Schutte U, Zhong X . Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012; 4(132):132ra52. PMC: 3722878. DOI: 10.1126/scitranslmed.3003605. View

17.

Srinivasan S, Hoffman N, Morgan M, Matsen F, Fiedler T, Hall R . Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One. 2012; 7(6):e37818. PMC: 3377712. DOI: 10.1371/journal.pone.0037818. View

18.

Nugent R, Krohn M, Hillier S . Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991; 29(2):297-301. PMC: 269757. DOI: 10.1128/jcm.29.2.297-301.1991. View

19.

Zarakolu P, Sahin Hodoglugil N, Aydin F, Tosun I, Gozalan A, Unal S . Reliability of interpretation of gram-stained vaginal smears by Nugent's scoring system for diagnosis of bacterial vaginosis. Diagn Microbiol Infect Dis. 2004; 48(2):77-80. DOI: 10.1016/j.diagmicrobio.2003.09.001. View

20.

Muench D, Kuch D, Wu H, Begum A, Veit S, Pelletier M . Hydrogen peroxide-producing lactobacilli inhibit gonococci in vitro but not during experimental genital tract infection. J Infect Dis. 2009; 199(9):1369-78. PMC: 2864085. DOI: 10.1086/597390. View